Zum Hauptinhalt springen

Fusion protein comprising antifreeze protein and human epidermal growth factor with increased anti-oxidant activity and skin cell proliferation effect and cosmetic composition for anti-wrinkle comprising the same as effective component

NEXGEN BIOTECHNOLOGIES, INC. ; Lee, Sun Kyo
2020
Online Patent

Titel:
Fusion protein comprising antifreeze protein and human epidermal growth factor with increased anti-oxidant activity and skin cell proliferation effect and cosmetic composition for anti-wrinkle comprising the same as effective component
Autor/in / Beteiligte Person: NEXGEN BIOTECHNOLOGIES, INC. ; Lee, Sun Kyo
Link:
Veröffentlichung: 2020
Medientyp: Patent
Sonstiges:
  • Nachgewiesen in: USPTO Patent Grants
  • Sprachen: English
  • Patent Number: 10815,284
  • Publication Date: October 27, 2020
  • Appl. No: 16/336990
  • Application Filed: August 31, 2017
  • Assignees: NEXGEN BIOTECHNOLOGIES, INC. (Seoul, KR), Lee, Sun Kyo (Gyeonggi-Do, KR)
  • Claim: 1. A fusion protein consisting of the amino acid sequence of SEQ ID NO: 5 or SEQ ID NO: 6.
  • Claim: 2. A gene encoding the fusion protein of claim 1 .
  • Claim: 3. The gene according to claim 2 , wherein the gene consists of any one of the nucleotide sequences of SEQ ID NOS: 1 or 2.
  • Claim: 4. A recombinant vector comprising the gene of claim 2 .
  • Claim: 5. A host cell transformed with the recombinant vector of claim 4 .
  • Claim: 6. A method for producing a fusion protein in a host cell, the method comprising transforming the host cell with the recombinant vector of claim 4 to overexpress the gene encoding the fusion protein.
  • Claim: 7. The method according to claim 6 , wherein the host cell is E. coli.
  • Claim: 8. A cosmetic composition comprising the fusion protein of claim 1 , and at least one selected from the group consisting of a lipid material, an organic solvent, a dissolution agent, a condensation agent, a gelling agent, a softening agent, an anti-oxidant, a suspension agent, a stabilizer, a foaming agent, an aroma, a surface active agent, water, an ionic or non-ionic emulsifier, a filler, a metal ion sequestering agent, a chelating agent, a preservative, vitamin, a blocking agent, a moisturizing agent, essential oil, a dye, a pigment, a hydrophilic activating agent, a lipophilic activating agent, a common auxiliary agent, and a carrier.
  • Claim: 9. The fusion protein of claim 1 , wherein the amino acid sequence is SEQ ID NO: 5.
  • Claim: 10. The fusion protein of claim 1 , wherein the amino acid sequence is SEQ ID NO: 6.
  • Claim: 11. A method for proliferating skin cells, the method comprising applying a composition comprising the fusion protein of claim 1 to the skin.
  • Claim: 12. A method for improving skin wrinkle, the method comprising applying a composition comprising the fusion protein of claim 1 to the skin.
  • Patent References Cited: 9321821 April 2016 Lee ; 10125181 November 2018 Lee ; 10266817 April 2019 Lee ; 10441632 October 2019 Lee ; 2006/0008440 January 2006 Blatt et al. ; 2016/0207962 July 2016 Ba et al. ; 63-3790 January 1988 ; WO 90/13571 November 1990 ; 2009-203184 September 2009 ; 10-1175803 August 2012 ; 10-1482187 January 2015 ; 10-2015-0056022 May 2015 ; 10-1636846 July 2016 ; 10-1636851 July 2016 ; 10-1661912 October 2016 ; 10-1678392 November 2016 ; WO 2014202089 December 2014
  • Other References: Machine translation of KR 10-1636851 (published Jul. 6, 2016). cited by examiner ; Machine translation of KR 10-1636846 (published Jul. 7, 2016). cited by examiner ; Machine translation of KR 10-1482187 (published Jan. 14, 2015). cited by examiner ; Machine translation of KR 10-1661912 (published Oct. 4, 2016). cited by examiner ; Chao et al., Protein Science (1994), 3:1760-1769. cited by examiner ; Ng et al., Journal of Biological Chemistry, vol. 261, No. 33, Issue of Nov. 25, pp. 15690-15695,1986. cited by examiner ; International Search Report for PCT/KR2017/009514 dated Dec. 11, 2017. cited by applicant ; Zheng, Xueming et al., “Expression and Purification of Human Epidermal Growth Factor (hEGF) Fused with GB I”, Biotechnology & Biotechnological Equipment, vol. 30, No. 4, Apr. 2016. cited by applicant ; Li, Jia-Je et al., “Development and Characterization of the Recombinant Human VEGF-EGF Dual-targeting Fusion Protein as a Drug Delivery System”, Bioconjugate Chemistry, vol. 26, No. 12, 2015. cited by applicant ; Hanahan, D., “Studies on Transformation of Escherichia coli with Plasmids”, Mol. Biol., 166, 557-580, Jan. 1983. cited by applicant ; Carpenter G et al. “Epidermal Growth Factor” The Journal of Biological Chemistry vol. 265, 1990. cited by applicant ; Fallon et al., “Epidermal Growth Factor Immunoreactive Material in the Central Nervous System: Location and Development” Science 224 (4653): 1107-1109, 1984. cited by applicant ; Office action dated Mar. 10, 2020 from Japan Intellectual Property Office in a counterpart Japanese Patent Application No. 2019-517042. cited by applicant ; Li-Ming et al.,“Thermal stability Properties of an antifreeze protein from the desert beetle Microdera punctipennis”, Cryobiology, vol. 60, pp. 192-197, 2010. cited by applicant ; Nancy F.L. Ng et al., “Structure of an Antifreeze Polypeptide from the Sea Raven” J. Biol. Chemistry., vol. 267, No. 23, pp. 16069-16075, 1992. cited by applicant
  • Primary Examiner: Allen, Marianne P
  • Attorney, Agent or Firm: The PL Law Group, PLLC

Klicken Sie ein Format an und speichern Sie dann die Daten oder geben Sie eine Empfänger-Adresse ein und lassen Sie sich per Email zusenden.

oder
oder

Wählen Sie das für Sie passende Zitationsformat und kopieren Sie es dann in die Zwischenablage, lassen es sich per Mail zusenden oder speichern es als PDF-Datei.

oder
oder

Bitte prüfen Sie, ob die Zitation formal korrekt ist, bevor Sie sie in einer Arbeit verwenden. Benutzen Sie gegebenenfalls den "Exportieren"-Dialog, wenn Sie ein Literaturverwaltungsprogramm verwenden und die Zitat-Angaben selbst formatieren wollen.

xs 0 - 576
sm 576 - 768
md 768 - 992
lg 992 - 1200
xl 1200 - 1366
xxl 1366 -